Alaska Permanent Fund Corp Has $2.22 Million Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Alaska Permanent Fund Corp boosted its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 29.3% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 102,423 shares of the pharmacy operator’s stock after buying an additional 23,211 shares during the period. Alaska Permanent Fund Corp’s holdings in Walgreens Boots Alliance were worth $2,222,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Dark Forest Capital Management LP raised its position in Walgreens Boots Alliance by 6.5% during the third quarter. Dark Forest Capital Management LP now owns 29,409 shares of the pharmacy operator’s stock valued at $654,000 after buying an additional 1,804 shares during the period. Quadrant Capital Group LLC increased its position in Walgreens Boots Alliance by 33.8% in the 4th quarter. Quadrant Capital Group LLC now owns 7,494 shares of the pharmacy operator’s stock worth $196,000 after purchasing an additional 1,893 shares during the last quarter. Syon Capital LLC acquired a new position in Walgreens Boots Alliance in the 4th quarter worth about $333,000. New York Life Investment Management LLC increased its position in Walgreens Boots Alliance by 0.6% in the 4th quarter. New York Life Investment Management LLC now owns 115,196 shares of the pharmacy operator’s stock worth $3,008,000 after purchasing an additional 690 shares during the last quarter. Finally, EP Wealth Advisors LLC acquired a new position in Walgreens Boots Alliance in the 4th quarter worth about $297,000. 58.59% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the company. Leerink Partnrs reiterated a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Monday, February 26th. Truist Financial reiterated a “hold” rating and set a $25.00 price target on shares of Walgreens Boots Alliance in a research note on Monday, April 1st. UBS Group decreased their price target on Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating for the company in a research note on Wednesday, April 3rd. TD Cowen decreased their price target on Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating for the company in a research note on Wednesday, April 3rd. Finally, Deutsche Bank Aktiengesellschaft decreased their price target on Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating for the company in a research note on Wednesday, April 3rd. Four research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $23.57.

Walgreens Boots Alliance Trading Down 1.5 %

Shares of WBA stock opened at $15.87 on Friday. The stock has a 50 day moving average of $16.87 and a two-hundred day moving average of $20.50. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 0.50. Walgreens Boots Alliance, Inc. has a 12 month low of $14.62 and a 12 month high of $32.53.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.82 by $0.38. The business had revenue of $37.05 billion during the quarter, compared to analysts’ expectations of $35.86 billion. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The firm’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter last year, the company posted $1.16 EPS. On average, research analysts expect that Walgreens Boots Alliance, Inc. will post 3.21 EPS for the current year.

Walgreens Boots Alliance Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st were given a dividend of $0.25 per share. The ex-dividend date of this dividend was Monday, May 20th. This represents a $1.00 dividend on an annualized basis and a yield of 6.30%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently -14.29%.

Insider Buying and Selling

In other Walgreens Boots Alliance news, CFO Manmohan Mahajan purchased 6,000 shares of the firm’s stock in a transaction that occurred on Tuesday, April 2nd. The shares were acquired at an average cost of $19.38 per share, for a total transaction of $116,280.00. Following the transaction, the chief financial officer now directly owns 166,969 shares in the company, valued at $3,235,859.22. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other news, CFO Manmohan Mahajan acquired 6,000 shares of the firm’s stock in a transaction on Tuesday, April 2nd. The shares were purchased at an average cost of $19.38 per share, for a total transaction of $116,280.00. Following the transaction, the chief financial officer now owns 166,969 shares of the company’s stock, valued at $3,235,859.22. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Inderpal S. Bhandari acquired 3,000 shares of the firm’s stock in a transaction on Thursday, April 11th. The stock was purchased at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the transaction, the director now directly owns 3,000 shares in the company, valued at approximately $54,150. The disclosure for this purchase can be found here. 17.40% of the stock is owned by corporate insiders.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.